RUBIN PAUL D
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to RUBIN PAUL D. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BIOA | Chief Medical Officer | Option Exercise | 18,000 | $6.57 | $118,260 | Dec 9, 2025 |
| BIOA | Chief Medical Officer | Sale | 68,897 | $10.19 | $702,060 | Dec 4, 2025 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 24,194 | $0.78 | $18,871 | Mar 18, 2016 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Award / Grant | 198,330 | — | — | Feb 25, 2016 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Disposition | 10,801 | $0.83 | $8,965 | Aug 14, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 5,000 | $3.04 | $15,200 | Jul 15, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 4,400 | $3.04 | $13,376 | Jul 9, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Other | 6,541 | $1.38 | $9,027 | Jun 30, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 4,666 | — | — | May 28, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 32,742 | $3.94 | $129,003 | Mar 23, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 18,205 | — | — | Mar 18, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Award / Grant | 64,900 | — | — | Feb 26, 2015 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Other | 1,114 | $4.95 | $5,514 | Dec 31, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 1,600 | $4.63 | $7,408 | Dec 15, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 5,000 | $4.55 | $22,750 | Nov 20, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 5,000 | $4.57 | $22,850 | Oct 28, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 5,000 | $3.04 | $15,200 | Sep 15, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 10,000 | $4.56 | $45,600 | Sep 4, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 10,299 | $4.31 | $44,389 | Aug 14, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 11,580 | $4.54 | $52,573 | Jun 16, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 4,667 | — | — | May 28, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 10,000 | $3.84 | $38,400 | May 13, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 18,205 | — | — | Mar 18, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Award / Grant | 68,793 | — | — | Feb 27, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 6,000 | $3.04 | $18,240 | Feb 18, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 5,694 | $3.04 | $17,310 | Jan 21, 2014 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Other | 888 | $6.61 | $5,870 | Dec 31, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 6,000 | $5.67 | $34,020 | Dec 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 4,696 | $3.04 | $14,276 | Nov 27, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 1,304 | $4.08 | $5,320 | Nov 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 5,254 | $4.71 | $24,746 | Oct 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 746 | $4.71 | $3,514 | Oct 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | L | 459 | $4.27 | $1,960 | Sep 30, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 6,000 | $4.53 | $27,180 | Sep 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 6,000 | $3.74 | $22,440 | Aug 19, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 26,748 | — | — | Aug 14, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 2,748 | $2.36 | $6,485 | Jul 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 567 | $3.45 | $1,956 | Jun 28, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 3,130 | — | — | Jun 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 4,667 | — | — | May 29, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 785 | $4.16 | $3,266 | May 20, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Sale | 6,000 | — | — | Apr 18, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 1,498 | $3.32 | $4,973 | Mar 28, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 18,205 | — | — | Mar 19, 2013 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 833 | $2.28 | $1,899 | Dec 31, 2012 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Other | 2,214 | $2.53 | $5,601 | Dec 31, 2012 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Option Exercise | 542 | $3.51 | $1,902 | Sep 28, 2012 |
| XOMAP | Sr. VP Clinical Dev. & CMO | Gift | 3,887 | — | — | Jun 29, 2012 |
| XOMAP | VP Clinical Dev. & CMO | Option Exercise | 1,229 | $2.63 | $3,232 | Mar 30, 2012 |
| XOMAP | VP Clinical Dev. & CMO | Other | 2,208 | $1.16 | $2,561 | Dec 30, 2011 |